(Q44407113)

2 December 2017

title

Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats (English)

1 reference

2 December 2017

Effects of Naltrexone Alone and In Combination With Acamprosate on the Alcohol Deprivation Effect in Rats (English)

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300175

25 December 2023

0 references

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300175

25 December 2023

3

George F Koob

1 reference

2 December 2017

Kelly Moc

2

1 reference

2 December 2017

Charles J. Heyser

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12700689

25 December 2023

George F. Koob

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12700689

25 December 2023

language of work or name

English

0 references

publication date

9 April 2003

1 reference

full work available at URL

2 December 2017

https://www.nature.com/articles/1300175.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12700689

http://www.nature.com/articles/1300175.pdf

25 December 2023

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300175

http://www.nature.com/articles/1300175

25 December 2023

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300175

25 December 2023

published in

Neuropsychopharmacology

1 reference

2 December 2017

volume

28

1 reference

2 December 2017

issue

8

1 reference

2 December 2017

page(s)

1463-1471

1 reference

Chronic ethanol increases proopiomelanocortin gene expression in the rat hypothalamus

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Alterations in mesolimbic dopamine function during the abstinence period following chronic ethanol consumption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

A homotaurine derivative reduces the voluntary intake of ethanol by rats: are cerebral GABA receptors involved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Acamprosate, but not naltrexone, inhibits conditioned abstinence behaviour associated with repeated ethanol administration and exposure to a plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Selectivity of Ligands for Opioid Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Acamprosate decreases the hypermotility during repeated ethanol withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Ethanol and amino acids in the central nervous system: assessment of the pharmacological actions of acamprosate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Pharmacological treatment of alcohol dependence: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Implications of endogenous opioids and dopamine in alcoholism: human and basic science studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Ethanol withdrawal seizures and the NMDA receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Endogenous opioid systems and alcohol addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Central administration of an opiate antagonist decreases oral ethanol self-administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Increased ethanol self-administration after a period of imposed ethanol deprivation in rats trained in a limited access paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Kappa-opioid receptors and relapse-like drinking in long-term ethanol-experienced rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Responding for oral ethanol after naloxone treatment by alcohol-preferring AA rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

The delta 2-opioid receptor antagonist naltriben reduces motivated responding for ethanol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Neurocircuitry targets in ethanol reward and dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Pharmacotherapies for alcohol problems: a review of research with focus on developments since 1991.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Central nervous system mechanisms in alcohol relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Ethanol regulates calcium channels in clonal neural cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Mechanism of action of acamprosate. Part I. Characterization of spermidine-sensitive acamprosate binding site in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

The anti-craving drug acamprosate reduces c-fos expression in rats undergoing ethanol withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Mechanism of action of acamprosate. Part II. Ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Chronic daily ethanol and withdrawal: 3. Forebrain pro-opiomelanocortin gene expression and implications for dependence, relapse, and deprivation effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Excessive ethanol drinking following a history of dependence: animal model of allostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Initiation of ethanol reinforcement using a sucrose-substitution procedure in food- and water-sated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Oral ethanol self-administration in the rat: effect of naloxone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Dopaminergic and opiate agonists and antagonists differentially decrease multiple schedule responding maintained by sucrose/ethanol and sucrose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Ethanol differentially regulates proadrenocorticotropin/endorphin production and corticosterone secretion in LS and SS lines of mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

A calcium channel antagonist stereoselectively decreases ethanol withdrawal hyperexcitability but not that due to bicuculline, in hippocampal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

From controlled drug intake to loss of control: the irreversible development of drug addiction in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

Effects of voluntary short-term abstinence from alcohol on subsequent drinking patterns of college students

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

7 January 2021

Increased dihydropyridine-sensitive calcium channels in rat brain may underlie ethanol physical dependence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

7 January 2021

Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

7 January 2021

Dose-dependent suppression of the high alcohol intake of chronically intoxicated rats by Ca-acetyl homotaurinate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

7 January 2021

The competitive NMDA receptor antagonist, CGP 39551, inhibits ethanol withdrawal seizures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

7 January 2021

Decrease in ethanol consumption by naloxone in naive and dependent rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

7 January 2021

Acamprosate for the treatment of alcohol dependence: a review of double-blind, placebo-controlled trials.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

7 January 2021

Interaction of acamprosate with ethanol and spermine on NMDA receptors in primary cultured neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

7 January 2021

Morphine and naloxone modulate intake of ethanol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

7 January 2021

Naloxone decreases ethanol consumption within a free choice paradigm in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

7 January 2021

Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

7 January 2021

Acamprosate and alcohol: II. Effects on alcohol withdrawal in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300175

7 January 2021

Molecular Pharmacology

5

16

91

K-J Chang

1979

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300175

25 December 2023

Identifiers

1 reference

2 December 2017

1 reference